The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
In a large, gender comparison study, researchers found that women with Hepatitis C are more likely than men to have several disadvantages after undergoing a liver transplant.
Continue reading »Recent data from a Phase II trial claims that twice daily dosing of telaprevir cured Hepatitis C in over 80 participants.
Continue reading »Recent data from a Phase II trial claims that twice daily dosing of telaprevir cured Hepatitis C in over 80 participants.
Continue reading »If choosing a doctor to help you fight the Hepatitis C virus feels overwhelming, you are not alone. To identify which physician fits your needs best, the nation's largest health insurer has developed a rating system for patients to evaluate their doctor and share their opinions.
Continue reading »By expanding the applicability of cellular array technology, learn how San Diego researchers may have found a direction for the therapeutic intervention of liver fibrosis.
Continue reading »Repeated studies prove that those with chronic hepatitis must be evaluated directly for fibrosis progression. Although your doctor or peers may single out a normal ALT from a liver panel as good news, discover why this measurement provides little information about liver fibrosis.
Continue reading »SciClone begins a Phase II trial to evaluate how a new drug designed to stimulate the immune system fares against Hepatitis C.
Continue reading »By focusing in on HCV polymerase NS5B, two companies join forces to develop new and effective medications for inhibiting the Hepatitis C virus.
Continue reading »Mixed cryoglobulinemia is a common extrahepatic manifestation of Hepatitis C. Although not much is known about why this vascular disease frequently accompanies the Hepatitis C virus, researchers have uncovered some new information.
Continue reading »Find out the strengths and weaknesses of immune globulin for preventing viral hepatitis.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
